New Treatment in Australia: A Promising Breakthrough for Reducing Body Weight?
Australia is eagerly anticipating the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor agonist , representing a potential advance in weight loss . Early clinical trials have demonstrated impressive results, showing greater efficacy than existing treatments like semaglutide. While